Accountable for end-to-end development of Cardiovascular programs from First In Human studies to commercialization.
Base: $383,206 - $464,355; Bonus/Equity: Additional incentive cash and stock opportunities may be available; Benefits: Health Coverage, Wellbeing Support, Financial Well-being and Protection, Work-life benefits
Must-have
Nice-to-have
Not specified